BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16029700)

  • 1. Ultrarapid staining for cutaneous melanoma: study and protocol.
    Davis DA; Kurtz KA; Robinson RA
    Dermatol Surg; 2005 Jul; 31(7 Pt 1):753-6; discussion 756. PubMed ID: 16029700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.
    Kligora CJ; Fair KP; Clem MS; Patterson JW
    Mod Pathol; 1999 Dec; 12(12):1143-7. PubMed ID: 10619267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
    Kamino H; Tam ST
    J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostaining melanoma frozen sections: the 1-hour protocol.
    Bricca GM; Brodland DG; Zitelli JA
    Dermatol Surg; 2004 Mar; 30(3):403-8. PubMed ID: 15008870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol.
    Cherpelis BS; Moore R; Ladd S; Chen R; Glass LF
    Dermatol Surg; 2009 Feb; 35(2):207-13. PubMed ID: 19215257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
    Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
    Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
    Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
    Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells.
    Mahmood MN; Lee MW; Linden MD; Nathanson SD; Hornyak TJ; Zarbo RJ
    Mod Pathol; 2002 Dec; 15(12):1288-93. PubMed ID: 12481009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
    Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
    J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin.
    Beltraminelli H; Shabrawi-Caelen LE; Kerl H; Cerroni L
    Am J Dermatopathol; 2009 May; 31(3):305-8. PubMed ID: 19384076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Analysis of Immunohistochemistry in Melanoma Tumors.
    Lilyquist J; White KAM; Lee RJ; Philips GK; Hughes CR; Torres SM
    Medicine (Baltimore); 2017 Apr; 96(15):e6432. PubMed ID: 28403073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine melanotic cutaneous lesions and lymph nodes: immunohistochemical differentiation of melanocytes and melanophages.
    Grossi AB; Hyttel P; Jensen HE; Leifsson PS
    Vet Pathol; 2015 Jan; 52(1):83-91. PubMed ID: 24503437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Staining in the Assessment of Melanoma Tumor Thickness.
    Kamyab-Hesary K; Ghanadan A; Balighi K; Mousavinia SF; Nasimi M
    Pathol Oncol Res; 2020 Apr; 26(2):885-891. PubMed ID: 30875030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
    Menaker GM; Chiang JK; Tabila B; Moy RL
    J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas.
    Drabeni M; Lopez-Vilaró L; Barranco C; Trevisan G; Gallardo F; Pujol RM
    Am J Dermatopathol; 2013 Feb; 35(1):56-63. PubMed ID: 22688397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna.
    Bowen AR; Thacker BN; Goldgar DE; Bowen GM
    Dermatol Surg; 2011 May; 37(5):657-63. PubMed ID: 21446989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new AJCC guidelines in practice: utility of the MITF immunohistochemical stain in the evaluation of single-cell metastasis in melanoma sentinel lymph nodes.
    Hutchens KA; Heyna R; Mudaliar K; Wojcik E
    Am J Surg Pathol; 2013 Jun; 37(6):933-7. PubMed ID: 23629445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.